PTAD-ergosta-3-one
PTAD-ergosta-3-one is a snake venom enzyme inhibitor. PTAD-ergosta-3-one inhibits the procoagulant activity of citrated plasma mediated by serine protease (SVSP) from Bothrops asper venom. PTAD-ergosta-3-one inhibits the esterase activity of PLA2 from Bothrops asper venom. PTAD-ergosta-3-one can be used in the research of snakebite envenoming.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 分子式: C37H51N3O3
- 分子量:585.82
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
Phospholipase アイソフォーム固有の製品をすべて表示
More
生物活性
|
PLA2 |
PTAD-ergosta-3-one (62.5-500 μM; 30 min) potently and dose-dependently inhibits the procoagulant activity of citrated plasma mediated by serine proteases from Bothrops asper venom (SVSP). Its activity reaches the peak at the concentration of 500 μM, prolonging the clotting time to 300 s[1].
PTAD-ergosta-3-one (62.5-500 μM; 30 min) weakly inhibits the amide hydrolysis activity mediated by Bothrops asper snake venom SVSP in vitro, and exhibits concentration-dependent variable effects within the tested concentration range[1].
PTAD-ergosta-3-one (250-500 μM; 30 min) inhibits the 4-NOBA monodisperse substrate-mediated esterase activity of Bothrops asper snake venom PLA2 in vitro at concentrations of 250 μM and 500 μM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
化学情報
-
分子量 585.82
-
分子式 C37H51N3O3
-
SMILES
[H][C@]12CC[C@]3(C)[C@@H]([C@@H](CC[C@@H](C)C(C)C)C)CC[C@@]3(C)[C@@]14C=C[C@]5(CC(CC[C@@]52C)=O)N6C(N(C7=CC=CC=C7)C(N64)=O)=O
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)